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Abstract
The three possible structural isomers of 4-(pyridyl)pyrimidine were employed for the synthesis of new pyrrolo[1,2-c]pyrimidines
and new indolizines, by 1,3-dipolar cycloaddition reaction of their corresponding N-ylides generated in situ from their corres-
ponding cycloimmonium bromides. In the case of 4-(3-pyridyl)pyrimidine and 4-(4-pyridyl)pyrimidine the quaternization reactions
occur as expected at the pyridine nitrogen atom leading to pyridinium bromides and consequently to new indolizines via the corres-
ponding pyridinium N-ylides. However, in the case of 4-(2-pyridyl)pyrimidine the steric hindrance directs the reaction to the py-
rimidinium N-ylides and, subsequently, to the formation of the pyrrolo[1,2-c]pyrimidines. The new pyrrolo[1,2-c]pyrimidines and
the new indolizines were structurally characterized through NMR spectroscopy. The X-ray structures of two of the starting ma-
terials, 4-(2-pyridyl)pyrimidine and 4-(4-pyridyl)pyrimidine, are also reported.
Introduction
Two heteroarenes linked through a single bond [1] proved to be
versatile structural motifs for a broad range of compounds with
applications as advanced fluorescent materials [2,3], ligands
[4,5], bioactive compounds [6], and for the design of dynamic
chemical devices [7-10]. The most accessible route to hybrid
heteroarenes is the direct coupling [1,11,12]. However, in some
cases alternative routes could be useful to achieve structural
variety [13]. An alternative route is to start from accessible
simple heteroarenes linked by a single bond and to transform
one of them or both into more complex structures [14,15].
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Figure 1: Examples of hybrid heteroarenes from the class of indolizines.
Figure 2: Starting 4-pyridylpyrimidines 6–8.
Nitrogen-containing compounds from the class of indolizines
and azaindolizines are known as fluorescent materials [2-4,15]
with applications as chemosensors [16] and as bioactive com-
pounds [17-20]. For example, starting from bispyridyl deriva-
tives such as 1 and 3, fluorescent compounds from the class of
indolizines, as for example compounds 2, 4 and 5 (Figure 1)
were obtained [14,15].
Based on our previous experience [21-25] we investigated the
synthesis and structural characterization of new pyrrolo[1,2-
c]pyrimidines that are 3-substituted with a pyridine unit and
new indolizines substituted in positions 6 or 7 with a pyrimi-
dine. Herein, we report the efficient synthesis of small libraries
of structurally diverse pyrrolo-fused heterocycles starting from
the 4-pyridylpyrimidine isomers via 1,3-dipolar cycloaddition
of corresponding N-ylides with several activated alkynes. The
biologic and luminescent properties of newly synthesized
3-pyridylpyrrolo[1,2-c]pyrimidine and 7-pyrimidinylindolizine
derivatives are under investigation.
Results and Discussion
Our purpose was to obtain new hetarylpyridines and
hetarylpyrimidines. Thus, starting from the 4-pyridylpyrimi-
dine isomers 6–8 (Figure 2) we have obtained new pyrrolo[1,2-
c]pyrimidines or pyrimidinyl-substituted indolizines. The syn-
thetic strategy was the 1,3-dipolar cycloaddition reaction of the
corresponding N-ylides [21-25]. The structural variety of the
compounds was determined by the series of dipolarophiles
employed. The new final compounds were structurally charac-
terized and our preliminary investigations suggest that some of
them possess relevant degrees of fluorescence.
For the synthesis of 4-pyridylpyrimidines 6–8 there are
some synthetic methods reported in the literature [26-29]. 4-(2-
Pyridyl)pyrimidine (6) was obtained according to Bejan et al.
[28] in 44% yield while the reaction for obtaining 4-(3-
pyridyl)pyrimidine did not work. However, we devised an
appropriate method for the synthesis of 4-pyridylpyrimidines,
analogous to that reported for the synthesis of 4-phenylpyrim-
idines [30]. Thus, by the reaction of trisformylaminomethane
and corresponding substituted acetylpyridines in the presence of
p-toluenesulfonic acid the 4-pyridylpyrimidines were obtained
in 20–25% yields. In the case of 4-(4-pyridyl)pyrimidine (8) the
reaction was carried out starting from trisformylaminomethane
and the 4-acetylpyridine hydrochloride, the reaction yield
increasing to 41%. The compounds were crystallized from
methylcyclohexane resulting in waxy crystals of 4-(2-pyridyl)-
pyrimidine with mp 75–78 °C (lit: [28], 77–80 °C), 4-(3-
pyridyl)pyrimidine with mp 85–88 °C (lit: [26], 89 °C) and
4-(4-pyridyl)pyrimidine with mp 131–133 °C (lit: [29],
132–133 °C).
The chemistry of 4-(2-pyridyl)pyrimidine (6) is rather scarce
compared to its structural 2,2’-bipyridyl analogue but should
raise interest for similar synthetic applicative purposes. Also the
isomers of 6, compounds 7 and 8, are of interest for coordina-
tion chemistry both as ligands and as bridging compounds. For
this reason we paid some attention to their structural characteri-
zation. To our knowledge the X-ray structures for the parent
compounds 6–8 were not reported previously and we thus
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attempted to obtain suitable single crystals. Only compounds 6
and 8 could be isolated as monocrystals and their X-ray struc-
tures were determined. Disordered models were necessarily
invoked to account for the requirement of molecular centrosym-
metry imposed by their respective crystallographic space
groups. The detailed description of the X-ray structures is given
below.
Having at our disposal 4-(2-pyridyl)pyrimidine (6), 4-(3-
pyridyl)pyrimidine (7), and 4-(4-pyridyl)pyrimidine (8) as
starting materials we managed to obtain new pyrrolo-fused
derivatives by 1,3-dipolar cycloaddition reactions of their




Counterintuitively, starting from 6, we obtained new
pyrrolo[1,2-c]pyrimidines 12 instead of the expected
indolizines. The nitrogen atom of the pyridine moiety is more
reactive and it is expected that the quaternization reaction takes
place preferentially at that atom, rather than at one of the
nitrogen atoms in the pyrimidine. However due to steric
hindrance, in the case of 6 the quaternization reaction takes
place at the N1 nitrogen of the pyrimidine leading to the corres-
ponding pyrimidinium bromides 11 (Scheme 1). The com-
pounds 11 and 12 are presented in Table 1.
Scheme 1: The synthesis of new pyrimidinium bromides 11 and
pyrrolo[1,2-c]pyrimidines 12.
No quaternization product at the N3 or at the nitrogen atom of
the pyridine is observed. The new bromides 11 were obtained in
good yields in acetone at room temperature by reacting 6 with
different bromoacetophenones, and they were characterized by
NMR spectroscopy which confirmed their structure. The
Table 1: The bromides 11 and the new pyrrolo[1,2-c]pyrimidines 12.
entry Ar E R yield mp (°C)
11a C6H5 — — 80 227–229
11b 4-ClC6H4 — — 87 222–223
11c 4-BrC6H4 — — 90 242–243
11d 3-NO2C6H4 — — 80 219–221
11e 4-NO2C6H4 — — 78 226–228
12a 4-BrC6H4 COMe H 41 263–265
12b 3-NO2C6H4 COMe H 46 255–257
12c C6H5 CO2Me H 52 218–219
12d 4-BrC6H4 CO2Me H 62 234–236
12e 3-NO2C6H4 CO2Me H 54 233–235
12f 4-ClC6H4 CO2Et H 40 204–205
12g 4-NO2C6H4 CO2Et H 48 218–220
12h 3-NO2C6H4 CO2Me CO2Me 45 246–248
1H NMR spectra of the bromides 11 confirm that the quater-
nization reaction took place at the N1 of the pyrimidine ring.
This was confirmed by the deshielding effect of the quaterniza-
tion at the N1 atom of the pyrimidine upon the atoms H-2, H-5
and H-6 (Figure 3).
The three sets of signals in the pyrimidine moiety appear as
expected, thus H-5 and H-6 appear as two doublet of doublets
(J = 6.6, 0.8, and J = 6.6, 1.7 Hz, respectively; H-5 may appear
as a doublet due to the small value of the coupling constant with
H-2). The hydrogen H-2 is the most deshielded and appears at
9.86–9.92 ppm (compared to 9.30 ppm in compound 6,
Figure 3) as a broad singlet due to the coupling with H-5 and
H-6. The atoms in the pyridine moiety appear as four sets of
signals with the expected multiplicities (they were assigned by
COSY and HETCOR experiments). The methylene protons
appear in the range 6.43–6.67 ppm as a sharp singlet for all the
compounds 11a–e. The 13C NMR spectra of 11a–e present all
the expected signals. The C=O is observed at about 190 ppm.
The most deshielded tertiary carbon atoms are C-2, C-6 and
C-3’, which are directly bonded to nitrogen atoms. The ali-
phatic carbon atom appears at 62.8–63.2 ppm. All the signals in
the benzoyl moieties appear as expected.
The pyrimidinium bromides 11 were allowed to react with
different activated alkynes in 1,2-epoxybutane under reflux with
stirring for 24 h, to obtain the new pyrrolo[1,2-c]pyrimidines 12
decorated with a pyridyl moiety. No trace of the corresponding
pyrrolo[1,2-a]pyrimidine was observed as previously reported
by us [31,32]. The yields were moderate to good.
The NMR data of compounds 12 show strong evidence for the
formation of the new compounds. The main 1H NMR features
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Figure 3: The 1H NMR spectra (DMSO-d6) of 4-(2-pyridyl)pyrimidine (6) and the corresponding bromides 11a–e (the aromatic region).
are the signals in the pyrrolo[1,2-c]pyrimidine which were
assigned by COSY and HETCOR 2D experiments. Thus, H-6
appears as a singlet at around 7.83–7.91 ppm confirming the
regioselectivity of the cycloaddition reaction in the case of com-
pounds 12a–g. The atoms H-1 and H-4 appear as two doublets
with J = 1.4 Hz (1.6 Hz in CDCl3 with TFA added). The signals
in the pyridine moiety and benzoyl moiety appear as expected.
The 13C NMR exhibits all the carbon atom signals as expected.
The CO signals appear in accordance with the nature of the
substituents. In the case when acetyl is replaced by a
carbomethoxy or a carboethoxy group C-5 is shielded from
around 118 ppm (12a,b) to around 108 ppm (12c–h). The
carbon C-1 is the most deshielded in all the series of com-
pounds due to its direct bond to two nitrogen atoms.
New indolizines starting from 4-(3-
pyridyl)pyrimidine and 4-(4-pyridyl)pyrimidine
In the case of 7 and 8 the reaction proceeds as expected, the
quaternization reactions taking place at the nitrogen atom in the
pyridine moiety compared to 4-(2-pyridyl)pyrimidine (6). The
reactions were carried out via a multicomponent approach by
mixing all the starting materials in 1,2-epoxybutane under
reflux. In some cases the isolation and characterization of the
intermediate bromide salts was performed and will be discussed
in each case.
Scheme 2: The synthesis of new pyridinium bromides 13a,b and
indolizines 14a–f.
In the case of pyridinium ylides generated from 4-(3-
pyridyl)pyrimidine (7), new indolizines 14a–f decorated with a
pyrimidine moiety were obtained (Scheme 2). The reaction
appears to be selective towards the indolizines 14. In some
cases the other possible indolizine (14A) was observed also in
the bulk reaction mass in low to medium quantities but was not
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Scheme 3: The synthesis of the new pyridinium bromides 15 and 7-pyrimidylindolizines 16a–f.
Table 2: The bromide salts 13 and the new 6-pyrimidinylindolizines 14.
entry Ar E R yield mp (°C)
13a C6H5 — — 90 214–215
13b 4-FC6H4 — — 78 218–222
14a 4-FC6H4 COMe H 64 242–244
14b C6H5 CO2Me H 68 199–200
14c 4-NO2C6H4 CO2Et H 48 247–249
14d 4-ClC6H4 CO2Et H 54 212–214
14e 4-FC6H4 CO2Et H 60 176–178
14f C6H5 CO2Me CO2Me 45 133–136
recovered, further work being in progress to investigate this
aspect. Due to the fact that the salts 13 are not easy to work up
we ran the reaction in a multicomponent approach and only in
two cases, 13a,b, we separated the salts and assigned their
structures by NMR spectroscopy. The 1H NMR spectra of the
bromides 13a and 13b show that the quaternization reaction
took place at the nitrogen atom of the pyridine. This was
concluded by assigning all the protons by COSY and HETCOR
experiments. For the pyrimidine the signals are easy to assign as
a doublet of doublets for H-5’ (J = 5.2, 1.3 Hz), H-6’ as a
doublet (J = 5.2 Hz) and H-2’ (which is the most deshielded
hydrogen atom in the pyrimidine moiety) as a doublet with
J = 1.3 Hz. The most deshielded proton is H-2 in the pyridine
moiety at about 10 ppm for both 13a and 13b. The multiplici-
ties of the hydrogen atoms in the pyridine moiety are more
complex but could be assigned by 2D experiments. Another
main feature of the spectra of 13a,b is the singlet of the methyl-
ene protons at ca. 6.70 ppm. The 13C NMR spectra present all
the expected signals. The C=O is observed at around 190 ppm.
The aliphatic carbon atom appears at around 66 ppm.
The new indolizines 14a–f were obtained in good yields
(Table 2) and were characterized through NMR spectroscopy.
The 1H NMR spectra of the indolizines 14 confirm their struc-
ture. The discrimination between the two possible isomers 14
and 14A was made on the basis of the multiplicity of the proton
signals which is unequivocal. The main features are the
signals of H-2 which appears as a singlet and H-5, the most
deshielded proton appearing as a multiplet in the range of
10.70–10.75 ppm. For the pyrimidine the spectra show three
sets of signals for each proton. These signals are easy to assign
for H-5’ and H-6’ as a doublet of doublets (J = 5.2, 1.4 Hz) and
a doublet (J = 5.2 Hz) respectively. The hydrogen H-2’ is the
most deshielded hydrogen atom in the pyrimidine moiety, as a
doublet with J = 1.4 Hz. The 13C NMR spectra present all the
expected signals. The most deshielded carbon atoms are C-2’
and C-5’ at 159 and 157 ppm, respectively for all the series of
compounds 14a–f. As in the case of pyrrolo[1,2-c]pyrimidines
12, replacing the acetyl group at C-1 with a carbomethoxy or
carboethoxy group induces a shielding effect on the C-1 atom
from 115 ppm in the case of 14a, to 104.8–108.1 ppm for
14b–f.
Similarly, in the case of pyridinium N-ylides generated from 8,
the new indolizines 16 were synthesized (Scheme 3) and struc-
turally characterized. Again, in the case of some compounds,
the salts were not easily purified and we preferred the multi-
component approach. However, we isolated and characterized
the bromides 15a,b (Table 3). The new 7-(pyrimidyl)indolizines
were obtained in moderate to good yields and were character-
ized by NMR spectroscopy. The 1H NMR spectra of the bro-
mides 15 show that the quaternization reaction took place at the
pyridine nitrogen atom. The first definitive indications are the
signals of the protons in the pyridine moiety, which appear as
doublet of doublets either in the starting 4-(4-pyridyl)pyrimi-
dine (8) or after quaternization in 15a,b. The positive charge at
the nitrogen induces a deshielding effect for H-2 and H-6 (see
numbering in Scheme 3) in 15a,b compared to 8. The four
protons were assigned as two doublets with J = 6.9 Hz. For the
Beilstein J. Org. Chem. 2015, 11, 1079–1088.
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Scheme 4: Reaction mechanism.
Table 3: The bromides 15a,b and the new 7-pyrimidinylindolizines
16a–f.
entry Ar E R yield mp (°C)
15a 4-BrC6H4 — — 90 264–268
15b 4-MeOC6H4 — — 88 238–240
16a C6H5 COMe H 44 236–238
16b 4-ClC6H4 COMe H 56 287–289
16c 4-FC6H4 COMe H 62 240–242
16d 4-BrC6H4 CO2Me H 50 281–282
16e 4-MeOC6H4 CO2Me H 54 249–250
16f 3-NO2C6H4 CO2Et H 42 208–210
pyrimidine, the signals are easily assigned similarly as for the
indolizines 14. Another main feature of the spectra of 15 is the
singlet of the methylene protons at 6.6 ppm. The 13C NMR
spectra present all the expected signals. The C=O is observed at
around 190 ppm.
The new compounds 16 were obtained by a multicomponent ap-
proach by mixing all the reagents in 1,2-epoxybutane and
heating under reflux for 48 h (Scheme 3). In some cases we
carried out the reaction in two steps by isolating the salts 15, the
yields being similar.
The 1H NMR spectra of the indolizines 16a–f confirm their
structure. All the atoms in the indolizine moiety were assigned
by COSY and HETCOR experiments. The main features are the
signal for H-2, which appears as a singlet, and those for H-5
which is the most deshielded proton, appearing as a doublet of
doublets with J = 7.4, 0.8 Hz. The pyrimidine moiety was
assigned as previously described for the compounds 15. The
13C NMR spectra present all the expected signals. As in the
case of pyrrolo[1,2-c]pyrimidines 12 and indolizines 14
replacing the acetyl group at C-1 with a carbomethoxy or
carboethoxy group induces a shielding effect on the C-1 atom
from 115 ppm for 16a–c, to 108 ppm in the case of 16d–f.
The reaction mechanism in all cases implies the attack of the
bromide salt of type 17 on the oxirane ring in the 1,2-epoxybu-
tane (Scheme 4). The reactive intermediate obtained by the ring
opening of the 1,2-epoxybutane abstracts a methylene proton
from the salt, generating the corresponding N-ylide (18) in situ.
The N-ylide reacts further with the acetylenic dipolarophile to
give a primary cycloadduct 19 which spontaneously rearranges
and dehydrogenates under the reaction conditions, to the final
aromatic compounds 20.
X-ray crystal structures of the starting
compounds 4-(2-pyridyl)pyrimidine (6)
and 4-(4-pyridyl)pyrimidine (8)
Full details of the structural solution and refinements are given
in Supporting Information File 1. Structural refinements were
non-routine owing to subtle disorder occurring in both crystals.
Taking into account the values of Z (the number of molecules
per unit cell) for the crystals of 6 and 8, their respective space
groups, P21/n and P−1, require that each molecule be located on
a centre of symmetry and hence be planar. Since neither mole-
cule possesses a centre of symmetry, this implies that they must
both be disordered in their respective crystals. Accordingly,
centrosymmetric structural models were proposed by consid-
ering the possible planar rotamers for both molecules as well as
the effect of adding a centre of inversion to each of these. The
disordered models assigned were consistent with the observed
difference Fourier electron densities, in particular those of the
hydrogen atoms, whose relative values indicated that the sites of
their parent atoms were either fully occupied by carbon atoms
or by nitrogen atoms, or partially occupied by carbon and
nitrogen atoms simultaneously.
Figure 4a and 4b show the molecular and crystal structures of
4-(2-pyridyl)pyrimidine (6). Here, all atoms in the molecule
have a site-occupancy factor (s.o.f.) equal to 1 except the atom
labeled ‘C4/N4’, where C and N atoms have equal occupancy
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(s.o.f. = 0.5 for each and for H-4), which is required to satisfy
the condition of centrosymmetry. The molecules are linked into
large concatenated rings with graph-set descriptor [33] R2
2(22)
by one crystallographically unique, weak C–H…N hydrogen
bond.
Figure 4: Molecular and crystal structures of 6 (a,b) and 8 (c,d). The
molecules are located on centers of inversion and their asymmetric
units are labelled, disordered atoms being indicated as Cn/Nn.
In the centrosymmetric structural model for 4-(4-pyridyl)pyrim-
idine (8) (Figure 4c), atom N4 is necessarily present with
s.o.f. = 1, but the evidence from the X-ray analysis indicated the
presence of rotamers, with both the 2- and the 6-positions in the
two rings occupied by C and N atoms with s.o.f. values of 0.75
and 0.25, respectively, to account for a net total of three carbon
atoms and one nitrogen atom. The crystal of 8 is composed of
layers, a portion of such a layer being shown in Figure 4d. Two
crystallographically distinct cyclic C–H…N hydrogen bonded
motifs with graph-set descriptor R2
2(6) occur [33] resulting in a
more extensive H-bonding in the crystal of 8 than in that of 6.
This is consistent with their significantly different melting
points (131–133 °C for 8 and 75–78 °C for 6). In both crystals,
C–H…N hydrogen bonding is complemented by offset
π-stacking, with shortest ring centroid-to-centroid distances of
3.743 Å in 6 and 3.766 Å in 8.
It was ascertained from a search of the Cambridge Structural
Database [34] (CSD) that the crystal of 6 is isostructural with
that of 4,4’-bipyrimidine as the trans-rotamer (CSD refcode
SACPAN). This is not surprising when one compares this mole-
cule with the centrosymmetric model of Figure 4a. Isostruc-
turality was established from closely matching unit cell parame-
ters and the common space group, and confirmed by the near
superposition of their simulated powder X-ray patterns (see
Supporting Information File 1). No isostructural analogues for 8
were evident.
Conclusion
In conclusion, we have obtained 20 new hybrid heteroarenes
from the class of indolizines and pyrrolo[1,2-c]pyrimidines by a
simple multicomponent or two-step approach. All compounds,
including the 9 intermediate bromide salts, were structurally
characterized by NMR spectroscopy. The biological and fluo-
rescence properties of the new synthesized compounds will be
intensely investigated further. Reported methods were
employed in obtaining the 4-pyridylpyrimidine isomers used as
starting materials. X-ray analyses of the 4-pyridylpyrimidines 6
and 8 were non-trivial, requiring refinement of disordered
models due to their location on centers of symmetry.
Experimental
General
Melting points were measured using a Boetius hot plate micro-
scope and are uncorrected. 1H NMR and 13C NMR spectra were
recorded on a Varian Gemini 300BB operating at 300 MHz for
1H and 75 MHz for 13C. The spectra were recorded in CDCl3 or
DMSO-d6 at 298 K and the chemical shifts are relative to TMS
used as the internal standard. The bidimensional correlations
spectra (COSY, HETCOR) were performed for complete
assignment of chemical shifts. Fourier-transform IR spectra (for
representative compounds) were recorded on a Bruker Vertex
70 spectrometer with horizontal device for attenuated
reflectance and diamond crystal, in a spectral window ranging
from 4000 to 400 cm−1 or on a Nicolet Impact 410 Spectrom-
eter in KBr pellets. Elemental analysis was performed on a
Perkin Elmer CHNS/O analyzer Series II 2400 apparatus and
the results were in agreement with the calculated values. All
starting materials and solvents were purchased from common
commercial suppliers and were used without purification unless
otherwise noted.
General procedure for obtaining 4-(2-
pyridyl)pyrimidinium bromides 11a–e
4-(2-Pyridyl)pyrimidine (10 mmol) and bromoacetophenones
(9) (10 mmol) were stirred in 50 mL acetone under reflux for
8 h and then were left at room temperature overnight. The pre-
cipitated 4-(2-pyridyl)pyrimidinium bromides 11a–e were
removed by filtration.
1-[2-Phenyl-2-oxoethyl]-4-(2-pyridyl)pyrimidinium bromide
(11a). Light brown crystals with mp 227–229 °C. Yield 80%.
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Anal. calcd for C17H14BrN3O: N, 11.80; found N, 12.13;
1H NMR (DMSO-d6, 300 MHz) δ 6.43 (s, 2H, CH2), 7.52–7.68
(m, 2H, H-3”, H-5”), 7.74–7.80 (m, 2H, H-4’, H-4”), 8.06–8.08
(m, 2H, H-2”, H-6”), 8.16 (td, J = 7.7, 1.9 Hz, 1H, H-5’),
8.63–8.65 (m, 1H, H-6’), 8.89 (m, 1H, H-3’), 9.04 (dd,
J = 6.6 Hz, 0.8 Hz, 1H, H-5), 9.32 (dd, J = 6.6, 1.7 Hz, 1H,
H-6), 9.75 (bs, 1H, H-2); 13C NMR (DMSO-d6, 75 MHz) δ
63.4 (CH2), 119.0 (C-5), 125.0 (C-6’), 128.9 (C-2”, C-6”),
129.3 (C-4’), 129.9 (C-3”, C-5”), 133.7, 150.2, 168.5 (C-4,
C-1’, C-1”), 135.7 (C-4”), 139.2 (C-5’), 151.5 (C-3’), 154.7
(C-6), 155.3 (C-2), 190.7 (COAr); IR (KBr, cm−1): 1696, 1627,
1550, 1450, 1341, 1213.
General procedure for obtaining
pyrrolo[1,2-c]pyrimidines 12a–h
4-(2-Pyridyl)pyrimidinium bromide (3 mmol) 11a–e previously
obtained and acetylenic dipolarophiles 10 (3.5 mmol) were
stirred under reflux in 20 mL 1,2-epoxybutane for 24 h.
The products were precipitated with ethanol and removed by
filtration. Further purification was made by crystallization from
ethanol or by column chromatography on Al2O3 using methyl-
ene chloride as eluent.
3-(2-Pyridyl)-5-acetyl-7-(4-bromobenzoyl)-pyrrolo[1,2-
c]pyrimidine (12a). Pale yellow powder with mp 263–265 °C.
Yield 41%. Anal. calcd for C21H14BrN3O2: C, 60.02; H, 3.36;
Br, 19.01; N, 10.00; found: C, 60.30; H, 3.65; Br, 19.24; N,
10.22; 1H NMR (CDCl3, 300 MHz) δ 2.60 (CH3), 7.64 (s, 4H,
H-2”, H-3”, H-5”, H-6”), 7.80 (s, 1H, H-6), 7.96–8.00 (m, 1H,
H-4’), 8.60 (td, J = 7.7, 1.9 Hz, 1H, H-5’), 8.70–8.73 (m, 1H,
H-6’), 8.86–8.89 (m, 1H, H-3’), 9.30 (d, J = 1.6 Hz, 1H, H-4),
10.49 (d, J = 1.6 Hz, 1H, H-1); 13C NMR (CDCl3+TFA,
75 MHz) δ 28.0 (CH3), 114.8 (C-4), 117.8 (C-5), 124.6, 128.8,
136.3, 138.5, 142.0, 146.5 (C-3, C-7, C-4a, C-1’, C-1”, C-4”),
124.3 (C-6’), 127.7 (C-4’), 130.3 (C-6), 130.7 (C-2”, C-6”),
132.9 (C-3”, C-5”), 138.6 (C-5’), 142.4 (C-3’), 147.7 (C-1),
185.5 (COAr), 197.5 (CO); IR (ATR, cm−1): 3054, 1650, 1627,
1585, 1469, 1328, 1217, 887.
Procedure for obtaining 4-(3-pyridyl)pyrimi-
dinium bromides 13a,b
4-(3-Pyridyl)pyrimidine (7, 10 mmol) and bromoacetophenone
(9) (10 mmol) were stirred in 50 mL acetone under reflux for
8 h and then were left at room temperature overnight. The pre-
cipitated bromides 13a,b were removed by filtration.
1-[2-Phenyl-2-oxoethyl]-3-(4-pyrimidinyl)pyridinium bromide
(13a). Red powder with mp 214–215 °C. Yield 90%. Anal.
calcd for C17H14BrN3O: N, 11.80; found N, 12.07; 
1H NMR
(DMSO-d6, 300 MHz) δ 6.71 (s, 2H, CH2), 7.65–7.70 (m, 2H,
H-3”, H-5”), 7.77–7.83 (m, 1H, H-4”), 8.08–8.12 (m, 2H, H-2”,
H-6”), 8.40 (dd, J = 5.2, 1.3 Hz, 1H, H-6’), 8.50 (dd, J = 8.2,
6.0 Hz, 1H, H-5), 9.14 (d, J = 5.2 Hz, 1H, H-5’), 9.24 (dt,
J = 6.0, 1.4 Hz, 1H, H-6), 9.44 (d, J = 1.3 Hz, 1H, H-2’), 9.48
(dt, J = 8.2, 1.4 Hz, 1H, H-4), 10.00 (m, 1H, H-2); 13C NMR
(DMSO-d6, 75 MHz) δ 66.6 (CH2), 118.5 (C-5’), 128.1 (C-5);
128.3 (C-2”, C-6”), 129.1 (C-3”, C-5”), 133.5, 135.5, 156.9
(C-3, C-4’, C-1”), 134.7 (C-4”), 143.9 (C-4), 145.4 (C-2), 147.6
(C-6), 159.0 (C-2’), 159.4 (C-6’), 190.6 (COAr).
General procedure for obtaining indolizines
14a–f
4-(3-Pyridyl)pyrimidine (7, 3 mmol), bromoacetophenones 9
(3 mmol) and different acetylenic dipolarophiles 10 (3.5 mmol)
were stirred at reflux in 20 mL 1,2-epoxybutane for 48 h.
The products were precipitated with ethanol and removed by
filtration. Further purification was made by crystallization from
ethanol or column chromatography on Silicagel-60 (Merck,
70–230 mesh) using methylene chloride as eluent.
1-Acetyl-3-(4-fluorobenzoyl)-6-(4-pyrimidinyl)indolizine
(14a). Yellow crystals with mp 242–244 °C. Yield 64%. Anal.
calcd for C21H14FN3O2: C, 70.19; H, 3.93; N, 11.69; found C,
70.40; H, 4.21; N, 11.88; 1H NMR (CDCl3, 300 MHz) δ 2.56
(s, 3H, CH3), 7.25 (t, J = 8.8 Hz, 1H, H-3”, H-5”), 7.74 (s, 1H,
H-2), 7.81 (dd, J = 5.2, 1.4 Hz, 1H, H-6’), 7.85–7.93 (m, 2H,
H-2”, H-6”), 8.23 (dd, J = 9.3, 1.6 Hz, 1H, H-7), 8.74 (dd,
J = 9.3, 1.1 Hz, 1H, H-8), 8.85 (d, J = 5.2, 1H, H-5’), 9.32 (d,
J = 1.4 Hz, 1H, H-2’), 10.71–10.72 (m, 1H, H-5); 13C NMR
(CDCl3 ,  75 MHz) δ  28.0 (CH3), 115.3 (C-1), 115.8
(J = 21.7 Hz, C-3”, C-5”), 116.7 (C-5’), 120.6 (C-8), 126.8
(C-7), 128.8 (C-5), 129.3 (C-2), 131.4 (J = 8.9 Hz, C-2”, C-6”),
122.8, 126.1, 135.7, 139.5, 160.9 (C-3, C-8a, C-6, C-4’, C-1”),
157.9 (C-6’), 159.4 (C-2’), 165.1 (J = 252.3 Hz, C-4”), 184.3
(COAr), 193.1 (CO); IR (KBr, cm−1): 1659, 1630, 1581, 1510,
1485, 1431, 1359, 1213, 1152.
General procedure for obtaining the
4-(4-pyrimidinyl)pyridinium bromides 15
4-(4-Pyridyl)pyrimidine (8) (10 mmol) and different bromo-
acetophenones 9 (10 mmol) were stirred in 50 mL acetone
under reflux for 8 h and then were left at room temperature
overnight. The precipitated bromides 15a,b were removed by
filtration.
1-[2-(4-Bromophenyl)-2-oxoethyl]-4-(4-pyrimidinyl)pyri-
dinium bromide (15a). Brown powder with mp 264–268 °C.
Yield 90%. Anal. calcd for C17H13Br2N3O: N, 9.66; found N,
9.73; 1H NMR (DMSO-d6, 300 MHz) δ 6.61 (s, 2H, CH2), 7.90
(d, J = 8.7 Hz, 2H, H-3”, H-5”), 8.02 (d, J = 8.7 Hz, 2H, H-2”,
H-6”), 8.54 (dd, J = 5.3, 1.3 Hz, H-5’), 9.01 (d, J = 6.9 Hz, 2H,
H-3, H-5), 9.21–9.24 (m, 3H, H-2, H-6, H-6’), 9.53 (d,
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J = 1.3 Hz, 1H, H-2’); 13C NMR (DMSO-d6, 75 MHz) δ 66.1
(CH2), 119.8 (C-5’), 125.0 (C-3, C-5), 128.9, 132.6, 151.5,
159.3 (C-4, C-1’, C-1”, C-4”), 130.3 (C-2”, C-6”), 132.3 (C-3”,
C-5”), 147.2 (C-2, C-6), 159.6 (C-6’), 159.9 (C-2’), 190.0
(COAr).
General procedure for obtaining the
indolizines 16a–f
4-(4-Pyridyl)pyrimidine (8) (3 mmol), bromoacetophenones 9
(3 mmol) and acetylenic dipolarophile 10 (3.5 mmol) in
20 mL 1,2-epoxybutane were stirred under reflux for 48 h.
The products were precipitated with ethanol and removed by
filtration. Further purification was performed by crystallization
from ethanol or column chromatography on Silicagel-60
(Merck) or neutral Al2O3 by using methylene chloride as an
eluent.
1-Acetyl-3-benzoyl-7-(4-pyrimidinyl)indolizine (16a). Yellow
crystals with mp 236–238 °C. Yield 44%. Anal. calcd for
C21H15N3O2: C, 73.89; H, 4.43; N, 12.31; found C, 74.11; H,
4.69; N, 12.59; 1H NMR (CDCl3, 300 MHz) δ 2.51 (s, 3H, Me),
7.48–7.58 (m, 3H, H-3”, H-4”, H-5”), 7.69 (s, 1H, H-2),
7.78–7.81 (m, 2H, H-2”, H-6”), 7.91 (dd, J = 5.3, 1.4 Hz, 1H,
H-5’), 7.95 (dd, J = 7.4, 1.9 Hz, 1H, H-6), 8.83 (d, J = 5.4 Hz,
1H, H-6’), 9.28 (dd, J = 1.9, 0.8 Hz, 1H, H-8), 9.30 (d,
J = 1.4 Hz, 1H, H-2’), 9.97 (dd, J = 7.4, 0.8 Hz, 1H, H-5);
13C NMR (CDCl3, 75 MHz) δ 28.0 (Me), 114.0 (C-6), 116.5
(C-1), 117.4 (C-5’), 119.0 (C-8), 123.2, 136.5, 138.9, 139.7,
161.0 (C-3, C-8a, C-7, C-1’, C-1”), 129.1 (C-5), 129.3 (C-2),
128.7, 129.1, 132.0 (C-2”, C-6”, C-3”, C-4”, C-5”), 158.1
(C-6’), 159.4 (C-2’), 185.9 (COAr), 193.4 (COMe); IR (KBr,
cm−1): 1655, 1616, 1575, 1507, 1394, 1348, 1229, 1193.
Supporting Information
Experimental procedures and structural characterization
(1H, 13C NMR data) for all newly synthesized compounds.
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